Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation

v3.23.3
Stock-Based Compensation
9 Months Ended
Sep. 30, 2023
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation

NOTE 11 — STOCK-BASED COMPENSATION

Stock-based compensation expense, which consists of the compensation cost for employee stock options and the value of options issued to non-employees for services rendered, was allocated to research and development and general and administrative in the consolidated statements of operations as follows (in thousands):

 

Three Months Ended
September 30,

Nine Months Ended
September 30,

 

    

2023

    

2022

    

2023

    

2022

Research and development

$

353

$

1,381

$

2,411

$

4,753

General and administrative

895

1,260

2,931

4,552

Total stock-based compensation

$

1,248

$

2,641

$

5,342

$

9,305

As of September 30, 2023, the total unrecognized compensation cost related to unvested stock-based awards granted to employees under the Company’s equity incentive plans was approximately $6.0 million. This cost will be recorded as compensation expense on a ratable basis over the remaining weighted average requisite service period of approximately 2.5 years.

Valuation Assumptions

The Company estimated the fair value of stock options granted using the Black-Scholes option-pricing formula and a single option award approach. This fair value is being amortized ratably over the requisite service periods of the awards, which is generally the vesting period.

The fair value of employee stock options was estimated using the following weighted-average assumptions:

 

Three Months Ended
September 30,

Nine Months Ended
September 30,

 

    

2023

    

2022

    

2023

    

2022

Employee Stock Options:

Risk-free interest rate

4.29

%  

3.25

%  

4.03

%  

2.33

%

Expected term (in years)

6.08

6.08

6.08

6.08

Dividend yield

Volatility

78.85

%  

83.32

%  

77.65

%  

88.70

%

Weighted-average fair value of stock options granted

$

5.82

$

7.95

$

5.23

$

24.90

Equity Incentive Plans

These plans consist of the 2018 Equity Incentive Plan; the 2014 Equity Incentive Plan, as amended; the 2004 Amended and Restated Equity Incentive Plan; and the Amended and Restated 2004 Employee Stock Purchase Plan. As of May 31, 2018, the 2014 Equity Incentive Plan; and the 2004 Amended and Restated Equity Incentive Plan were terminated, and no further shares will be granted from those plans.

The following table summarizes stock option activity under the Company’s equity incentive plans:

    

Outstanding Options
Number of Shares

    

Weighted Average
Exercise Price

    

Weighted Average
Remaining
Contractual Term

    

Aggregate Intrinsic
Value (in millions):

Balances, December 31, 2021

523,411

$

153.11

6.72

$

14.25

Granted

194,679

$

33.09

Exercised

(3,106)

$

10.65

Cancelled

(152,106)

$

141.63

Balances, December 31, 2022

562,878

$

115.50

7.09

$

Granted

213,168

$

7.46

Exercised

(192)

$

7.20

Cancelled

(241,027)

$

82.61

Balances, September 30, 2023

534,827

$

87.30

6.61

$

Vested and expected to vest, September 30, 2023

534,827

$

87.30

6.61

$

Exercisable at September 30, 2023

327,184

$

118.84

5.05

$

The total intrinsic value of stock options exercised during the nine months ended both September 30, 2023 and 2022, was zero, as determined at the date of the option exercise.

Cash received from stock option exercises was zero, for both the nine months ended September 30, 2023 and 2022. The Company issues new shares of common stock upon exercise of options.